SAN DIEGO , Oct. 31, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX ), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate at several upcoming investor conferences.
Details of the company's participation are as follows: Truist Healthcare Conference Details: Viking management will participate in a fireside chat and in 1-on-1 meetings Conference Date: November 7, 2024 Fireside Chat Timing: 12:30 – 1:00 p.m. Eastern on Thursday, November 7, 2024 Location: New York, NY UBS Global Healthcare Conference Details: Viking management will participate in 1-on-1 meetings Conference Dates: November 11-14, 2024 Location: Rancho Palos Verdes, CA Stifel 2024 Healthcare Conference Details: Viking management will deliver a corporate presentation and participate in 1-on-1 meetings Conference Dates: November 18-19, 2024 Presentation Timing: 8:35 – 9:05 a.
m. Eastern on Tuesday, November 19, 2024 , webcast available Location: New York, NY Jefferies London Healthcare Conference 2024 Details: Viking management will deliver a corporate presentation and participate in 1-on-1 meetings Conference Dates: November 19-21, 2024 Presentation Timing: 9:00 – 9:25 a.m.
GMT on Thursday, November 21, 2024 Location: London, UK A live webcast of the Stifel presentation may be accessed via a link on the Viking Therapeutics website in the Investors & Media sectio.